Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine

The American Journal of Psychiatry
Tarek K RajjiGary J Remington


Clozapine's potent antagonism of muscarinic M1 receptors is thought to worsen working memory deficits associated with schizophrenia. In contrast, its major metabolite, N-desmethylclozapine (NDMC), is thought to enhance working memory via its M1 receptor agonist activity. The authors hypothesized that the ratio of serum clozapine and NDMC concentrations would be inversely associated with working memory performance in schizophrenia. Thirty patients with schizophrenia or schizoaffective disorder who were receiving clozapine monotherapy at bedtime completed the MATRICS Consensus Cognitive Battery (MCCB) on the day their blood was collected to assess concentrations of clozapine and NDMC as well as serum anticholinergic activity. The clozapine/NDMC ratio was significantly and negatively associated with working memory performance after controlling for age, gender, education, and symptom severity. No significant associations were found between individual clozapine and NDMC concentrations and working memory performance. Serum anticholinergic activity was significantly associated with clozapine concentration, but not with working memory performance or NDMC concentration. No significant associations were found between any pharmacological ...Continue Reading


Dec 1, 2015·Pharmacology & Therapeutics·Giuseppe Di Giovanni, Philippe De Deurwaerdère
Aug 25, 2015·Schizophrenia Research·Alfredo SpagnaJin Fan
Jul 1, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Irina PiatkovMark McLean
Apr 6, 2018·Journal of Clinical Psychopharmacology·Leif HommersStefan Unterecker
Mar 31, 2018·Therapeutic Drug Monitoring·Donatella MarazzitiLiliana DellʼOsso
Aug 23, 2018·Pharmacogenetics and Genomics·Caroline F ThornTeri E Klein
Feb 3, 2018·Journal of Clinical Psychopharmacology·George SavulichEmilio Fernandez-Egea
Aug 1, 2019·Acta Neuropsychiatrica·Dilhan Esen-SehirFlorian Freudenberg
Dec 21, 2018·Frontiers in Psychiatry·Nicole E MacKenzieMargaret K Hahn
Jun 28, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Frederick C NuciforaAkira Sawa
Jun 20, 2019·European Archives of Psychiatry and Clinical Neuroscience·M AlbusH Küchenhoff

Related Concepts

Memory, Short-Term
Immediate Recall
Schizoaffective Disorder
Memory Impairment
Memory for Designs Test

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here